Episode

On Rare Innovators: Nasha Fitter is Redefining the Rare Disease Playbook – “Who says we can’t do this?”

Podcast
On Rare
Published
Dec 10, 2025
Duration seconds
2621
Processing state
not_requested
Canonical source
https://onrarebridgebio.podbean.com/e/on-rare-innovators-nasha-fitter-is-redefining-the-rare-disease-playbook-%e2%80%93-who-says-we-can-t-do-this/
Audio
https://mcdn.podbean.com/mf/web/vj9ueaxn9v5g289y/On_Rare_Innovators_-_Nasha_final_56mmfu.mp3
JSON
/v1/public/podcasts/on-rare-5037493/episodes/on-rare-innovators-nasha-fitter-is-redefining-the-rare-disease-playbook-who-says-we-can-t-do-this
Markdown
/podcast/on-rare-5037493/on-rare-innovators-nasha-fitter-is-redefining-the-rare-disease-playbook-who-says-we-can-t-do-this.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/on-rare-5037493/episodes/on-rare-innovators-nasha-fitter-is-redefining-the-rare-disease-playbook-who-says-we-can-t-do-this/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/on-rare-5037493/on-rare-innovators-nasha-fitter-is-redefining-the-rare-disease-playbook-who-says-we-can-t-do-this.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode of On Rare Innovators, Mandy Rohrig, Senior Director of Patient Advocacy at BridgeBio, and David Rintell, Head of Patient Advocacy at BridgeBio, talk with Nasha Fitter, a parent, entrepreneur, and rare disease leader whose determination was reshaped the day her daughter Amara was diagnosed with FOXG1 syndrome. Drawing on a career defined by bold pivots and purpose-driven problem solving, Nasha is challenging long-held assumptions about what small, rare disease communities can achieve. From building the FOXG1 Research Foundation to co-founding Citizen Health, she has pushed for new models of data, drug development, and patient empowerment. Nasha’s story is a reminder that innovation often begins with a single question: “Who says we can’t do this?”